← FDA Drug Approvals (Drugs@FDA)
OZANIMOD
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2026-07-13
Drug application
- FDA Application #
ANDA219450
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OZANIMOD
- Generic name
- Ozanimod
- Active ingredients
- OZANIMOD
- Dosage form
- CAPSULE
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- APOTEX INC
- First approval
- 2026-07-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown